phosphines is required for optimum results. The high vacuum
needed to accomplish this is simply not available in a typical
pilot plant. In addition, LAH is often used for the reduction,
and this is a hazardous substance to handle on large scale.
We also wanted to avoid a two-step procedure for the
transformation. The reduction has been performed with
neutral silanes such as diphenylsilane,7 yet temperatures in
excess of 200 °C are often used. This is beyond the upper
working temperature (∼150 °C) of most types of plant
reactor systems. SPOs have been reduced with electron-
deficient silanes such as trichlorosilane, usually in refluxing
toluene or xylene, with added amines.8 Trichlorosilane has
both a low flash point (-13 °C) and low boiling point (31
°C) and is used at temperatures far above its boiling point.
This approach was therefore rejected on safety grounds.
Mechanistically, trichlorosilane is the electrophilic partner
in a nucleophilic attack by the SPO oxygen. This type of
reduction is therefore known to be quite difficult in the case
of electron-deficient phosphine oxides,9 and we were par-
ticularly interested in the reduction of these substrates. LAH
alone has also been used for this reduction,10 yet it presents
handling difficulties, is nonchemoselective, and most im-
portantly, can lead to primary phosphine impurities through
aryl C-P bond cleavage.11 The reduction of SPOs has
also been achieved with borane, in a significant advance
recently made by Pietrusiewicz.12 However, a recent severe
industrial accident with borane has been reported,13 reducing
the enthusiasm for large-scale use of this reagent which is
used in considerable excess in the reported procedure. The
latter method can also lead to significant amounts of the
borane adduct of the phosphinous acid tautomer as an
impurity.
We screened a series of commercially available reducing
agents with diphenylphosphine oxide and quickly found that
diisobutylaluminum hydride (DIBAL-H) effected clean
reduction to diphenylphosphine in minutes at ambient
temperature. This reducing agent has never been reported
for the reduction of SPOs,14 although it was reported more
than 25 years ago for the reduction of triphenylphosphine
oxide.15
DIBAL-H is an inexpensive aluminum alkyl which is
available in bulk in “process friendly” solvents such as
toluene, heptane, and THF. This is due to its central role in
the polymer industry for the production of polyethylene and
polybutadiene under Ziegler-Natta catalysis.16 We therefore
screened a series of diaryl SPOs with DIBAL-H, as shown
in Table 1. Our screening conditions used 3 equiv of DIBAL-
H/THF at ambient temperature, and all initial substrates
(entries 1-10) were reduced within the time required to reach
the spectrometer (∼10 min). The extremely electron-rich17a
p-NMe2 derivative (12, σP ) -0.83) as well as the methoxy-
substituted SPOs 13 and 14, however, all required 5 equiv
of DIBAL-H to reach completion at 25-35 °C. It seems
likely that 2 equiv of reducing agent are chelated unproduc-
tively to the heteroatoms in these species.
We next evaluated lower reaction temperatures and
reduced DIBAL-H charges. Many of the diaryl substrates
could actually be reduced between -78 and -20 °C. The
DIBAL-H charge could also be reduced to ∼1.5 equiv in
many cases, although this was ultimately found to depend
on the hydration state of the SPOs. A few of the phosphine
oxides crystallized as hydrates. We have found that both
coulometric and volumetric Karl Fisher water determinations
on SPOs are very treacherousswe routinely oberved “false
positives” for these species and subsequently found that only
TGA-IR in conjunction with DSC and elemental analysis
could reveal the true hydration state of these substrates. As
expected, the hydrates require additional DIBAL-H to effect
the reduction. We next focused on arylalkyl and dialkyl
SPOs. Phenylisopropylphosphine oxide 15 was reduced in
ca. 10 min at ambient temperature, yet phenyl-tert-butyl-
phosphine oxide 16 showed no reduction after several hours
at 25 °C. This substrate was cleanly reduced in 4 h at 50
(3) For selected examples, see the following. SNAr: (a) Williams, J. M.
J.; Coote, S. J.; Dawson, G. J.; Frost, C. G. Synlett 1993, 509. SN2: (b)
Sakai, T.; Kodama, T.; Fujimoto, T.; Ohta, K.; Yamamoto, I.; Kakehi, A.
J. Org. Chem. 1994, 59 (23), 7144 (c) Heidel, H.; Huttner, G.; Helmchen,
G. Z. Naturforsch. B 1993, 48 (11), 1681. (d) Imamoto, T.; Oshiki, T.;
Onozawa, T.; Sato, K. J. Am. Chem. Soc. 1990, 112 (13), 5244. Michael:
(e) Blinn, D. A.; Button, R. S.; Farazi, V.; Neeb, M. K.; Tapley, C. L. J.
Organomet. Chem. 1990, 393 (1), 143. (f) Lavenot, L.; Bortoletto, M. H.;
Roucoux, A.; Larpent, C.; Patin, H. J. Organomet. Chem. 1996, 509 (1), 9.
Hydrophosphination: (g) Shulyupin, M. O.; Kazankova, M. A.; Beletskaya,
I. P. Org. Lett. 2002, 4 (5), 761. (h) Kawaoka, A. M.; Marks, T. J. J. Am.
Chem. Soc. 2004, 126 (40), 12764. Cross-coupling: (i) Herd, O.; Hessler,
A.; Hingst, M.; Tepper, M.; Stelzer, O. J. Organomet. Chem. 1996, 522,
69. (j) Cai, D.; Payack, J. F.; Bender, D. R.; Hughes, D. L.; Verhoeven, T.
R.; Reider, P. J. J. Org. Chem. 1994, 59 (23), 7180. (k) Kraatz, H.-B.;
Pletsch, A. Tetrahedron: Asymmetry 2000, 11, 1617. (l) Hillhouse, J. H.
U. S. Pat. 5,550,295, 1996.
(4) Busacca, C. A. U. S. Pat. 6,316,620, 2001; European Patent 1218388.
Boehringer-Ingelheim Phosphinoimidazolines.
(5) (a) Busacca, C. A.; Grossbach, D.; Campbell, S. J.; Dong, Y.;
Eriksson, M. C.; Harris, R. E.; Jones, P.-J.; Kim, J.-Y.; Lorenz, J. C.;
McKellop, K. B.; O’Brien, E. M.; Qiu, F.; Simpson, R. D.; Smith, L.; So,
R. C.; Spinelli, E. M.; Vitous, J.; Zavattaro, C. J. Org. Chem. 2004, 69
(16), 5187. (b) Busacca, C. A.; Grossbach, D.; So, R. C.; O’Brien, E. M.;
Spinelli, E. M. Org. Lett. 2003, 5 (4), 595. (c) Menges, F.; Neuburger, M.;
Pfaltz, A. Org. Lett. 2002, 4 (26), 4713. (d) Boland, N. A.; Casey, M.;
Hynes, S. J.; Matthews, J. W.; Smyth, M. P. J. Org. Chem. 2002, 67 (11),
3919. (e) Guiu, E.; Claver, C.; Benet-Buchholz, J.; Castillon, S. Tetrahedron:
Asymmetry 2004, 15 (21), 3365.
(6) (a) Rajanbabu, T. V.; Casalnuovo, A. L.; Ayers, T. A.; Warren, T.
H. J. Am. Chem. Soc. 1994, 116 (22), 9869. (b) Lam, H.; Aldous, D. J.;
Hii, K. K. Tetrahedron Lett. 2003, 44 (28), 5213.
(7) Livinghouse, T.; McKinstry, L. Tetrahedron 1994, 50 (21), 6145.
(8) (a) Dong, X.; Erkey, C. J. Mol. Catal. A 2004, 211, 73. (b) Elding,
L. I.; Kellenberger, B.; Venanzi, L. M. HelV. Chim. Acta 1983, 66(6),
1676.
(9) (a) Hayashi, T.; Hirate, S.; Kitayama, K.; Tsuji, H.; Torii, A.; Uozumi,
Y. J. Org. Chem. 2001, 66 (4), 1441. (b) Wu, H.-C.; Yu, J.-Q.; Spencer, J.
B. Org. Lett. 2004, 6 (25), 4675.
(10) (a) Kapoor, P. N.; Venanzi, L. M. HelV. Chim. Acta 1977, 60 (277),
2824. (b) Fehring, V.; Kadyrov, R.; Ludwig, M.; Holz, J.; Haage, K.; Selke,
R. J. Organomet. Chem. 2001, 1-2, 120. (c) Miller, P. W.; Nieuwenhuyzen,
M.; Xu, X.; James, S. L. Chem. Commun. 2002, 18, 2008.
(12) Pietrusiewicz, K. M.; Stankevic, M. Synlett 2003, 7, 1012.
(13) Reisch, M. Chem. Eng. News 2002, 80 (26), 7.
(14) Busacca, C. A.; Lorenz, J. C. U. S.Pat. Appl. Ser. No. 11/034,089
Jan 13, 2004; Int. Appl. No. PCT/US05/01526.
(15) GB 1,520,237, Appl. No. 18850/77, 1977.
(16) For reviews see (a) Monakov, Y. B.; Sabirov, Z. M.; Urazbaev, V.;
Zaikov, G. E. Polymer Yearbook 2003, 18, 75. (b) Monakov, Y. B.; Sabirov,
Z. M.; Zaikov, G. E. New. DeV. Chem. Biochem. 2003, 53. See also (c)
Natta, G.; Mazzanti, G.; Giorgio, D.; Gino, S.; Sartori, G.; Motroni, G. IT
Pat. 718796, 1966. (d) Ziegler, K. Chem. Ber. 1964, 76, 545.
(17) (a) Hansch, C.; Leo, A.; Unger, S. H.; Kim, N. H.; Nikaitani, D.;
Lien, E. J. J. Med. Chem. 1973, 16 (11), 1207. (b) 31P NMR δ -123 ppm,
(11) Treatment of (3,5-F2-C6H3)2POH with LAH from 0 to 25 °C leads
to a mixture of the desired secondary phosphine and 3,5-difluorophe-
1
1
nylphosphine, 31P NMR δ -121 ppm, t, JP-H ) 203 Hz.
t, JP-H ) 206 Hz.
4278
Org. Lett., Vol. 7, No. 19, 2005